JFNAX vs. FSPHX

In the year-to-date period, JFNAX achieves a -4.76% return, which is significantly higher than FSPHX's -7.41% return. Over the past 10 years, JFNAX has underperformed FSPHX with an annualized return of 0.80%, while FSPHX has yielded a comparatively higher 6.14% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

JFNAX has a 0.98% expense ratio, which is higher than FSPHX's 0.69% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund Class A (JFNAX) and Fidelity® Select Health Care Portfolio (FSPHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current JFNAX Sharpe Ratio is -0.70, which is lower than the FSPHX Sharpe Ratio of -0.34. The chart below compares the historical Sharpe Ratios of JFNAX and FSPHX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

JFNAX's dividend yield for the trailing twelve months is around 6.03%, more than FSPHX's 0.02% yield.

The maximum JFNAX drawdown since its inception was -36.53%, smaller than the maximum FSPHX drawdown of -91.65%. Use the drawdown chart below to compare losses from any high point for JFNAX and FSPHX. For additional features, visit the drawdowns tool.

Janus Henderson Global Life Sciences Fund Class A (JFNAX) has a higher volatility of 7.21% compared to Fidelity® Select Health Care Portfolio (FSPHX) at 6.51%. This indicates that JFNAX's price experiences larger fluctuations and is considered to be riskier than FSPHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.